Xencor XNCR
NASDAQ XNCR
$26.53 -0.09 (-0.32%)
As of: Sep 4, 2026 · 2:25 PM EDT

Xencor (XNCR) Research & Development (2013 - 2026)

Xencor (XNCR) posted quarterly Research & Development of $64.7 million for Q1 2026, up 10.4% year-over-year from $58.6 million in Q1 2025, and little changed quarter-over-quarter from $64.8 million in Q4 2025.

Analysis

Xencor (XNCR) Research & Development (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Research & Development for 14 consecutive years, with $64.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Research & Development rose 10.4% year-over-year to $64.7 million; the TTM figure through Mar 2026 stood at $245.5 million (up 7.03% YoY), while the FY2025 annual figure was $239.4 million, up 5.16% from the prior year.
  • Research & Development steadied at $64.7 million in Q1 2026 per XNCR's latest filing, from $64.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $64.9 million in Q3 2023 and bottomed at $47.1 million in Q2 2022.
  • Historically, Research & Development has averaged $57.9 million across 5 years, with a median of $58.6 million in 2025.
  • Annual changes were most pronounced in 2023 — Research & Development jumped 34.81% — and 2024, when it dropped 20.5%.
  • Xencor's Research & Development stood at $51.5 million in 2022, then gained by 24.82% to $64.2 million in 2023, then fell by 20.5% to $51.1 million in 2024, then climbed by 26.97% to $64.8 million in 2025, then decreased by 0.24% to $64.7 million in 2026.
  • Business Quant data shows XNCR's Research & Development at $64.7 million in Q1 2026, $64.8 million in Q4 2025, and $54.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -486.00 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 651.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 394.92 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 612.28 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 413.13 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 97.90 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 210.03 Mn
10 Xencor 2.01 Bn 1.64 Bn - 71.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.91 Mn
Mar 31, 2026 64.67 Mn
Dec 31, 2025 64.82 Mn
Sep 30, 2025 54.37 Mn
Jun 30, 2025 61.67 Mn
Mar 31, 2025 58.58 Mn
Dec 31, 2024 51.06 Mn
Sep 30, 2024 58.23 Mn
Jun 30, 2024 61.53 Mn
Mar 31, 2024 56.87 Mn
Dec 31, 2023 64.22 Mn
Sep 30, 2023 64.94 Mn
Jun 30, 2023 60.06 Mn
Mar 31, 2023 64.38 Mn
Dec 31, 2022 51.45 Mn
Sep 30, 2022 53.27 Mn
Jun 30, 2022 47.08 Mn
Mar 31, 2022 47.76 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 50.61 Mn